13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
10:52 am Invited Talk: Interrogating Signaling Networks at the Single Cell Level in Primary Human Patient Samples @ Acharya Hall
Invited Talk: Interrogating Signaling Networks at the Single Cell Level in Primary Human Patient Samples @ Acharya Hall
Aug 13 @ 10:52 am – 11:22 am
Invited Talk: Interrogating Signaling Networks at the Single Cell Level in Primary Human Patient Samples @ Acharya Hall | Vallikavu | Kerala | India
Michelle Hermiston, MD, Ph.D. Assistant Professor, Department of Pediatrics University of California San Francisco, USA Interrogating Signaling Networks at the Single Cell Level In Primary Human Patient Samples Multiparameter phosphoflow cytometry is a highly sensitive proteomic approach that enables monitoring of
11:25 am Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall
Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall
Aug 13 @ 11:25 am – 11:40 am
Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall | Vallikavu | Kerala | India
Shigeki Miyamoto, Ph.D. Professor, McArdle Laboratory for Cancer Research – UW Carbone Cancer Center Department of Oncology, School of Medicine and Public Health University of Wisconsin-Madison “Inside-out” NF-κB signaling in cancer and other pathologies The NF-κB/Rel family of transcription factors contributes to critical
3:26 pm Invited Talk: Probing Estrogen Receptor – Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall
Invited Talk: Probing Estrogen Receptor – Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall
Aug 13 @ 3:26 pm – 3:57 pm
Invited Talk: Probing Estrogen Receptor - Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall | Vallikavu | Kerala | India
Gokul Das, Ph.D. Co-Director, Breast Disease Site Research Group, Roswell Park Cancer Institute, Buffalo, NY Probing Estrogen Receptor−Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial Tumor suppressor p53 and estrogen receptor have opposite roles in the
4:25 pm Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall
Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall
Aug 13 @ 4:25 pm – 5:04 pm
Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall | Vallikavu | Kerala | India
Shrikant Anant, Ph.D. The Department of Molecular & Integrative Physiology, Kansas University Medical Center, USA Cancer Stem Cells: Target Colon Cancers Shrikant Anant, Deep Kwatra and Dharmalingam Subramaniam Colon cancer is a leading cause of cancer related deaths in the
6:26 pm Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall
Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall
Aug 13 @ 6:26 pm – 6:38 pm
Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall | Vallikavu | Kerala | India
Tanu Sharma, Narendra Parihar, Someshwar Nath, Azad Singh, Savneet Kaur, Simendra Singh and Chandi Mandal. In the recent years, there has been a surge in various forms of cancers especially in urban areas of India. Tumor recurrence and metastasis are